Cardiovascular diseases (CVDs) account for the majority of NCD deaths (17.9 million each year), followed by cancer (9.0 million), respiratory diseases (3.9 million), and diabetes (1.6 million). Each year, 15 million people between the ages of 30 and 69 die from NCDs, and more than 85% of these premature deaths occur in low- and middle-income countries. However, using wearable devices without healthy personal habits will cause disappointing results in the patient’s health.Īccording to the World Health Organization (WHO), noncommunicable diseases (NCDs) kill 41 million people each year, which is equivalent to 71% of global deaths. Noncommercial wearables focus on monitoring electrocardiogram and photoplethysmography data, and they mostly include accelerometers and smartwatches for detecting atrial fibrillation and heart failure. Our main findings revealed that commercial wearables usually include smart wristbands, patches, and smartwatches, and they generally monitor variables such as heart rate, blood oxygen saturation, and electrocardiogram data. In this work, we review commercial and noncommercial wearable devices used to monitor CVD biomedical variables. Nowadays, technological advance has contributed to wearables technology by reducing the size of the devices, improving the accuracy of sensing biomedical variables to be devices with relatively low energy consumption that can manage security and privacy of the patient’s medical information, have adaptability to any data storage system, and have reasonable costs with regard to the traditional scheme where the patient must go to a hospital for an electrocardiogram, thus contributing a serious option in diagnosis and treatment of CVDs. An effective strategy to mitigate the burden of CVDs has been to monitor patients’ biomedical variables during daily activities with wearable technology. Cardiovascular diseases (CVDs) are the leading cause of death globally.
0 kommentar(er)
